Rank | Gene Set | Z-score |
---|---|---|
1 | killing of cells of other organism (GO:0031640) | 9.68330487 |
2 | disruption of cells of other organism (GO:0044364) | 9.68330487 |
3 | defense response to fungus (GO:0050832) | 9.63651217 |
4 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 9.05562137 |
5 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 9.05562137 |
6 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 8.88011416 |
7 | response to fungus (GO:0009620) | 7.79704979 |
8 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 7.58119575 |
9 | regulation of growth of symbiont in host (GO:0044126) | 7.58119575 |
10 | negative regulation of growth of symbiont in host (GO:0044130) | 7.58119575 |
11 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 7.58119575 |
12 | * antibacterial humoral response (GO:0019731) | 7.41356864 |
13 | * innate immune response in mucosa (GO:0002227) | 7.06906231 |
14 | neutrophil mediated immunity (GO:0002446) | 7.04537371 |
15 | * antimicrobial humoral response (GO:0019730) | 6.82189495 |
16 | cellular extravasation (GO:0045123) | 6.81014248 |
17 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 6.42109755 |
18 | response to peptidoglycan (GO:0032494) | 6.36443665 |
19 | oxygen transport (GO:0015671) | 6.25782002 |
20 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.90104632 |
21 | negative regulation of interleukin-8 production (GO:0032717) | 5.80902959 |
22 | * mucosal immune response (GO:0002385) | 5.67668136 |
23 | hydrogen peroxide catabolic process (GO:0042744) | 5.63325045 |
24 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.59495038 |
25 | neutrophil activation involved in immune response (GO:0002283) | 5.50766075 |
26 | hemoglobin metabolic process (GO:0020027) | 5.47498346 |
27 | myeloid leukocyte mediated immunity (GO:0002444) | 5.43941896 |
28 | * organ or tissue specific immune response (GO:0002251) | 5.40608921 |
29 | imidazole-containing compound metabolic process (GO:0052803) | 5.33289787 |
30 | detection of bacterium (GO:0016045) | 5.31416559 |
31 | cell killing (GO:0001906) | 5.26776462 |
32 | gas transport (GO:0015669) | 5.24640627 |
33 | detection of other organism (GO:0098543) | 5.24183331 |
34 | neutrophil activation (GO:0042119) | 5.21708746 |
35 | granulocyte activation (GO:0036230) | 4.62631326 |
36 | negative regulation of phagocytosis (GO:0050765) | 4.59231518 |
37 | cell wall macromolecule catabolic process (GO:0016998) | 4.35287306 |
38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30364984 |
39 | superoxide anion generation (GO:0042554) | 4.27586791 |
40 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.25528118 |
41 | respiratory burst (GO:0045730) | 4.20918664 |
42 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.17684508 |
43 | reactive oxygen species biosynthetic process (GO:1903409) | 4.14296542 |
44 | regulation of chemokine biosynthetic process (GO:0045073) | 4.05418156 |
45 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.91503215 |
46 | heme biosynthetic process (GO:0006783) | 3.87973178 |
47 | positive regulation of B cell differentiation (GO:0045579) | 3.87230609 |
48 | * defense response to Gram-positive bacterium (GO:0050830) | 3.85779295 |
49 | hydrogen peroxide metabolic process (GO:0042743) | 3.76306697 |
50 | regulation of mast cell degranulation (GO:0043304) | 3.73509722 |
51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.69747680 |
52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63198587 |
53 | microglial cell activation (GO:0001774) | 3.60574487 |
54 | tetrapyrrole biosynthetic process (GO:0033014) | 3.60248988 |
55 | * defense response to bacterium (GO:0042742) | 3.59143032 |
56 | cell wall macromolecule metabolic process (GO:0044036) | 3.58196445 |
57 | angiotensin maturation (GO:0002003) | 3.51749529 |
58 | regulation of leukocyte degranulation (GO:0043300) | 3.47585869 |
59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.46825846 |
60 | leukotriene biosynthetic process (GO:0019370) | 3.36947914 |
61 | detection of external biotic stimulus (GO:0098581) | 3.36940341 |
62 | erythrocyte development (GO:0048821) | 3.26686019 |
63 | porphyrin-containing compound metabolic process (GO:0006778) | 3.24616878 |
64 | positive regulation of granulocyte differentiation (GO:0030854) | 3.22855227 |
65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.20946282 |
66 | regulation of female gonad development (GO:2000194) | 3.18802922 |
67 | erythrocyte maturation (GO:0043249) | 3.18514262 |
68 | negative regulation of interleukin-6 production (GO:0032715) | 3.16571408 |
69 | * response to bacterium (GO:0009617) | 3.15599750 |
70 | macrophage differentiation (GO:0030225) | 3.13896250 |
71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.13773983 |
72 | leukocyte mediated cytotoxicity (GO:0001909) | 3.13157984 |
73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.13119556 |
74 | positive regulation of mast cell degranulation (GO:0043306) | 3.13119556 |
75 | regulation of regulated secretory pathway (GO:1903305) | 3.11313339 |
76 | myeloid cell development (GO:0061515) | 3.11190283 |
77 | leukocyte aggregation (GO:0070486) | 3.08427991 |
78 | heme metabolic process (GO:0042168) | 3.07480170 |
79 | leukocyte degranulation (GO:0043299) | 3.07471297 |
80 | definitive hemopoiesis (GO:0060216) | 3.07223351 |
81 | detection of biotic stimulus (GO:0009595) | 3.06498977 |
82 | response to muramyl dipeptide (GO:0032495) | 3.05551755 |
83 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.05530884 |
84 | regulation of natural killer cell differentiation (GO:0032823) | 3.04218580 |
85 | response to methylmercury (GO:0051597) | 3.02057589 |
86 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.02011597 |
87 | interaction with symbiont (GO:0051702) | 2.99284135 |
88 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.94272477 |
89 | modification of morphology or physiology of other organism (GO:0035821) | 2.92548109 |
90 | mannose metabolic process (GO:0006013) | 2.90903584 |
91 | regulation of mast cell activation (GO:0033003) | 2.86808352 |
92 | leukotriene metabolic process (GO:0006691) | 2.83551302 |
93 | superoxide metabolic process (GO:0006801) | 2.83341650 |
94 | negative regulation of bone mineralization (GO:0030502) | 2.82883427 |
95 | mast cell activation (GO:0045576) | 2.79567580 |
96 | positive regulation of mast cell activation (GO:0033005) | 2.79113289 |
97 | regulation of B cell differentiation (GO:0045577) | 2.78376511 |
98 | regulation of response to osmotic stress (GO:0047484) | 2.73513081 |
99 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.71324430 |
100 | myeloid cell activation involved in immune response (GO:0002275) | 2.66427059 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 5.31708808 |
2 | VDR_24763502_ChIP-Seq_THP-1_Human | 4.35938160 |
3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.20152590 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70771656 |
5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.60580892 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.48398897 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.33985103 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.26227231 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18394905 |
10 | * SPI1_23547873_ChIP-Seq_NB4_Human | 3.05247125 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67995639 |
12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61470117 |
13 | GATA1_19941826_ChIP-Seq_K562_Human | 2.59971070 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54365720 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.31248074 |
16 | MYC_22102868_ChIP-Seq_BL_Human | 2.29508620 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26160813 |
18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24055797 |
19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23344626 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18518324 |
21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13640458 |
22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13293959 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09375563 |
24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07693362 |
25 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.05562155 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04435333 |
27 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.01891491 |
28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01706405 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98559251 |
30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96281291 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 1.95222149 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88983971 |
33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86134261 |
34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84974391 |
35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.83938692 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82082227 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.77848131 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77451364 |
39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76799219 |
40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76494007 |
41 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.74987439 |
42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74060408 |
43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71109149 |
44 | GATA2_19941826_ChIP-Seq_K562_Human | 1.69354063 |
45 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.69321647 |
46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68747348 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64831894 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59054507 |
49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57743700 |
50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.55035380 |
51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54658881 |
52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50942494 |
53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50044172 |
54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46749160 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.46487663 |
56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44931657 |
57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42318546 |
58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40907079 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40676953 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39198631 |
61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38053579 |
62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36952110 |
63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36288023 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35973810 |
65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35556115 |
66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35452419 |
67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35000923 |
68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29977215 |
69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28891997 |
70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28192540 |
71 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.25395633 |
72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23057805 |
73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23009045 |
74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21825805 |
75 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.21076195 |
76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18344915 |
77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17860838 |
78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17748694 |
79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17427527 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16874475 |
81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16261586 |
82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16103461 |
83 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14293558 |
84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12208607 |
85 | P68_20966046_ChIP-Seq_HELA_Human | 1.11364322 |
86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10216443 |
87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10005490 |
88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06897149 |
89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04429472 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04167343 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99164088 |
92 | P300_27268052_Chip-Seq_Bcells_Human | 0.98600941 |
93 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96543309 |
94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96513714 |
95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96316070 |
96 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94249265 |
97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94146783 |
98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93062262 |
99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91365817 |
100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91343397 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.85816624 |
2 | MP0004147_increased_porphyrin_level | 4.75955921 |
3 | MP0003656_abnormal_erythrocyte_physiolo | 4.38104850 |
4 | MP0002419_abnormal_innate_immunity | 3.30121058 |
5 | MP0003436_decreased_susceptibility_to | 3.28132087 |
6 | MP0003172_abnormal_lysosome_physiology | 3.18511295 |
7 | MP0009278_abnormal_bone_marrow | 3.15425504 |
8 | MP0005025_abnormal_response_to | 3.13776600 |
9 | MP0001545_abnormal_hematopoietic_system | 3.02265548 |
10 | MP0005397_hematopoietic_system_phenotyp | 3.02265548 |
11 | MP0009785_altered_susceptibility_to | 3.00347397 |
12 | MP0005464_abnormal_platelet_physiology | 2.80916836 |
13 | MP0001835_abnormal_antigen_presentation | 2.58808228 |
14 | MP0005058_abnormal_lysosome_morphology | 2.35190691 |
15 | MP0002396_abnormal_hematopoietic_system | 2.30026436 |
16 | MP0002420_abnormal_adaptive_immunity | 2.12809549 |
17 | MP0001819_abnormal_immune_cell | 2.08570899 |
18 | MP0002398_abnormal_bone_marrow | 2.03318536 |
19 | MP0005083_abnormal_biliary_tract | 1.98320685 |
20 | MP0005000_abnormal_immune_tolerance | 1.93832715 |
21 | MP0004808_abnormal_hematopoietic_stem | 1.93741494 |
22 | MP0002166_altered_tumor_susceptibility | 1.80210052 |
23 | MP0001800_abnormal_humoral_immune | 1.78271539 |
24 | MP0002722_abnormal_immune_system | 1.74451968 |
25 | MP0002452_abnormal_antigen_presenting | 1.74011011 |
26 | MP0002009_preneoplasia | 1.72678436 |
27 | MP0002148_abnormal_hypersensitivity_rea | 1.71691242 |
28 | MP0000716_abnormal_immune_system | 1.71145388 |
29 | MP0002723_abnormal_immune_serum | 1.66992267 |
30 | MP0000685_abnormal_immune_system | 1.66428380 |
31 | MP0002429_abnormal_blood_cell | 1.61680037 |
32 | MP0000689_abnormal_spleen_morphology | 1.60597501 |
33 | MP0002405_respiratory_system_inflammati | 1.58206002 |
34 | MP0005075_abnormal_melanosome_morpholog | 1.57950241 |
35 | MP0000465_gastrointestinal_hemorrhage | 1.57712460 |
36 | MP0003724_increased_susceptibility_to | 1.55955645 |
37 | MP0001533_abnormal_skeleton_physiology | 1.53982367 |
38 | MP0000015_abnormal_ear_pigmentation | 1.52873022 |
39 | MP0003763_abnormal_thymus_physiology | 1.52456318 |
40 | MP0008260_abnormal_autophagy | 1.50442189 |
41 | MP0001851_eye_inflammation | 1.49354420 |
42 | MP0001845_abnormal_inflammatory_respons | 1.49201931 |
43 | MP0004185_abnormal_adipocyte_glucose | 1.47688002 |
44 | MP0003828_pulmonary_edema | 1.45818848 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.44926814 |
46 | MP0009764_decreased_sensitivity_to | 1.40287027 |
47 | MP0005387_immune_system_phenotype | 1.40235389 |
48 | MP0001790_abnormal_immune_system | 1.40235389 |
49 | MP0000569_abnormal_digit_pigmentation | 1.35446747 |
50 | MP0001853_heart_inflammation | 1.35304831 |
51 | MP0005174_abnormal_tail_pigmentation | 1.34316063 |
52 | MP0006082_CNS_inflammation | 1.33916030 |
53 | MP0005671_abnormal_response_to | 1.31330487 |
54 | MP0002132_abnormal_respiratory_system | 1.23701403 |
55 | MP0000703_abnormal_thymus_morphology | 1.19006658 |
56 | MP0009333_abnormal_splenocyte_physiolog | 1.15097717 |
57 | MP0009379_abnormal_foot_pigmentation | 1.14929870 |
58 | MP0008469_abnormal_protein_level | 1.10743893 |
59 | MP0005076_abnormal_cell_differentiation | 1.09472589 |
60 | MP0002006_tumorigenesis | 1.09278507 |
61 | MP0002095_abnormal_skin_pigmentation | 1.07020055 |
62 | MP0008057_abnormal_DNA_replication | 1.06960465 |
63 | MP0003806_abnormal_nucleotide_metabolis | 1.05393419 |
64 | MP0005164_abnormal_response_to | 1.05115948 |
65 | MP0001986_abnormal_taste_sensitivity | 1.02723341 |
66 | MP0010155_abnormal_intestine_physiology | 1.02448218 |
67 | MP0009763_increased_sensitivity_to | 0.99147477 |
68 | MP0004947_skin_inflammation | 0.94026069 |
69 | MP0003183_abnormal_peptide_metabolism | 0.93696111 |
70 | MP0003075_altered_response_to | 0.92597455 |
71 | MP0003300_gastrointestinal_ulcer | 0.91019578 |
72 | MP0006036_abnormal_mitochondrial_physio | 0.89789908 |
73 | MP0002019_abnormal_tumor_incidence | 0.89525801 |
74 | MP0009765_abnormal_xenobiotic_induced | 0.88804403 |
75 | MP0003045_fibrosis | 0.87665014 |
76 | MP0002877_abnormal_melanocyte_morpholog | 0.83995618 |
77 | MP0008995_early_reproductive_senescence | 0.80370745 |
78 | MP0008873_increased_physiological_sensi | 0.79689952 |
79 | MP0005319_abnormal_enzyme/_coenzyme | 0.79682946 |
80 | MP0005636_abnormal_mineral_homeostasis | 0.79038515 |
81 | MP0000858_altered_metastatic_potential | 0.78010132 |
82 | MP0009931_abnormal_skin_appearance | 0.77351271 |
83 | MP0004883_abnormal_blood_vessel | 0.75564274 |
84 | MP0001663_abnormal_digestive_system | 0.72722962 |
85 | MP0005390_skeleton_phenotype | 0.71726915 |
86 | MP0003795_abnormal_bone_structure | 0.71713859 |
87 | MP0005266_abnormal_metabolism | 0.70381408 |
88 | MP0000249_abnormal_blood_vessel | 0.69151629 |
89 | MP0000598_abnormal_liver_morphology | 0.68932622 |
90 | MP0002998_abnormal_bone_remodeling | 0.68380460 |
91 | MP0005666_abnormal_adipose_tissue | 0.67626019 |
92 | MP0005376_homeostasis/metabolism_phenot | 0.61712790 |
93 | MP0000343_altered_response_to | 0.61165813 |
94 | MP0003186_abnormal_redox_activity | 0.61022302 |
95 | MP0010094_abnormal_chromosome_stability | 0.60043930 |
96 | MP0008961_abnormal_basal_metabolism | 0.60009591 |
97 | MP0005535_abnormal_body_temperature | 0.59719459 |
98 | MP0003111_abnormal_nucleus_morphology | 0.59599719 |
99 | MP0003638_abnormal_response/metabolism_ | 0.57270411 |
100 | MP0004381_abnormal_hair_follicle | 0.57069002 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypochromic microcytic anemia (HP:0004840) | 8.99276789 |
2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.97246135 |
3 | Hypochromic anemia (HP:0001931) | 5.34559299 |
4 | Thrombocytosis (HP:0001894) | 5.19921783 |
5 | Microcytic anemia (HP:0001935) | 4.84362955 |
6 | Obstructive lung disease (HP:0006536) | 4.78091803 |
7 | Chronic obstructive pulmonary disease (HP:0006510) | 4.78091803 |
8 | Recurrent abscess formation (HP:0002722) | 4.67862632 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.66188930 |
10 | Poikilocytosis (HP:0004447) | 4.47596345 |
11 | Abnormal hemoglobin (HP:0011902) | 4.24224479 |
12 | Granulocytopenia (HP:0001913) | 3.98575137 |
13 | Eczematoid dermatitis (HP:0000976) | 3.91804982 |
14 | Polycythemia (HP:0001901) | 3.86941107 |
15 | Prolonged bleeding time (HP:0003010) | 3.70605830 |
16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.68891912 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.62653212 |
18 | Paralysis (HP:0003470) | 3.50804227 |
19 | Abnormality of macrophages (HP:0004311) | 3.50386184 |
20 | Meningitis (HP:0001287) | 3.50292920 |
21 | Abnormality of iron homeostasis (HP:0011031) | 3.49384653 |
22 | Epistaxis (HP:0000421) | 3.45079157 |
23 | Abnormality of the prostate (HP:0008775) | 3.37478853 |
24 | Myositis (HP:0100614) | 3.25409179 |
25 | Petechiae (HP:0000967) | 3.22626747 |
26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20983860 |
27 | Periodontitis (HP:0000704) | 3.19272699 |
28 | Stomatitis (HP:0010280) | 3.15971599 |
29 | Amyloidosis (HP:0011034) | 3.13945255 |
30 | Cholelithiasis (HP:0001081) | 3.11445364 |
31 | Eosinophilia (HP:0001880) | 3.10539998 |
32 | Recurrent skin infections (HP:0001581) | 3.07521284 |
33 | Recurrent fungal infections (HP:0002841) | 3.01087220 |
34 | Osteomyelitis (HP:0002754) | 3.00839529 |
35 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.00636835 |
36 | Toxemia of pregnancy (HP:0100603) | 2.98638348 |
37 | Chest pain (HP:0100749) | 2.97459832 |
38 | Mediastinal lymphadenopathy (HP:0100721) | 2.93654361 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86999322 |
40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86999322 |
41 | Cellulitis (HP:0100658) | 2.78954420 |
42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74571121 |
43 | Urticaria (HP:0001025) | 2.74344923 |
44 | Abnormal gallbladder morphology (HP:0012437) | 2.73558028 |
45 | Gingivitis (HP:0000230) | 2.72916832 |
46 | Reticulocytosis (HP:0001923) | 2.71494205 |
47 | Hepatosplenomegaly (HP:0001433) | 2.68921203 |
48 | Thrombophlebitis (HP:0004418) | 2.68617528 |
49 | Skin rash (HP:0000988) | 2.67804565 |
50 | Increased serum ferritin (HP:0003281) | 2.67394362 |
51 | Leukocytosis (HP:0001974) | 2.61388924 |
52 | Agammaglobulinemia (HP:0004432) | 2.60455175 |
53 | Acute lymphatic leukemia (HP:0006721) | 2.58542460 |
54 | Pallor (HP:0000980) | 2.58227766 |
55 | Hemoptysis (HP:0002105) | 2.54675325 |
56 | Increased cerebral lipofuscin (HP:0011813) | 2.53702654 |
57 | Diaphragmatic weakness (HP:0009113) | 2.48272837 |
58 | Abnormality of B cell number (HP:0010975) | 2.48219049 |
59 | Vasculitis (HP:0002633) | 2.45634197 |
60 | Pulmonary infiltrates (HP:0002113) | 2.45064462 |
61 | Autoimmune thrombocytopenia (HP:0001973) | 2.41917783 |
62 | Gastrointestinal infarctions (HP:0005244) | 2.37794595 |
63 | Acute myeloid leukemia (HP:0004808) | 2.37621825 |
64 | Gingival bleeding (HP:0000225) | 2.36519983 |
65 | Abnormality of T cell physiology (HP:0011840) | 2.36348961 |
66 | B lymphocytopenia (HP:0010976) | 2.35708445 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.33947151 |
68 | Recurrent viral infections (HP:0004429) | 2.33549491 |
69 | Skin ulcer (HP:0200042) | 2.32760822 |
70 | Ureteral stenosis (HP:0000071) | 2.31836971 |
71 | Sepsis (HP:0100806) | 2.31660248 |
72 | Increased IgE level (HP:0003212) | 2.30624027 |
73 | Abnormality of eosinophils (HP:0001879) | 2.28688112 |
74 | Paresthesia (HP:0003401) | 2.26687942 |
75 | Dysostosis multiplex (HP:0000943) | 2.25258625 |
76 | Abnormality of the fingertips (HP:0001211) | 2.22430454 |
77 | Ureteral obstruction (HP:0006000) | 2.22093224 |
78 | Acanthocytosis (HP:0001927) | 2.18356516 |
79 | Abnormality of reticulocytes (HP:0004312) | 2.18166797 |
80 | Abnormality of the pericardium (HP:0001697) | 2.16348795 |
81 | Vacuolated lymphocytes (HP:0001922) | 2.12038388 |
82 | Panhypogammaglobulinemia (HP:0003139) | 2.11349108 |
83 | Systemic lupus erythematosus (HP:0002725) | 2.08976858 |
84 | Ileus (HP:0002595) | 2.08803509 |
85 | Thoracic kyphosis (HP:0002942) | 2.08041809 |
86 | Hypertensive crisis (HP:0100735) | 2.06447223 |
87 | Abnormality of the gallbladder (HP:0005264) | 2.04982103 |
88 | Pulmonary embolism (HP:0002204) | 2.04827960 |
89 | Abnormality of the pleura (HP:0002103) | 2.04563373 |
90 | Spondylolisthesis (HP:0003302) | 2.03823351 |
91 | Abnormal platelet function (HP:0011869) | 2.02470899 |
92 | Impaired platelet aggregation (HP:0003540) | 2.02470899 |
93 | Pulmonary fibrosis (HP:0002206) | 2.00827305 |
94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99841570 |
95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99841570 |
96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99841570 |
97 | Glomerulopathy (HP:0100820) | 1.99652567 |
98 | Cutaneous photosensitivity (HP:0000992) | 1.96670197 |
99 | Abnormality of male internal genitalia (HP:0000022) | 1.94889175 |
100 | Pustule (HP:0200039) | 1.94602212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP2K3 | 4.44159825 |
2 | RIPK4 | 4.25391466 |
3 | GRK6 | 3.37320313 |
4 | FES | 3.20434833 |
5 | PRPF4B | 3.09381624 |
6 | TEC | 2.57094115 |
7 | ERN1 | 2.49543758 |
8 | TNK2 | 2.43832859 |
9 | TESK2 | 2.20046918 |
10 | KIT | 2.16482610 |
11 | BTK | 2.07021256 |
12 | TAOK1 | 2.07006831 |
13 | SYK | 2.06169653 |
14 | MAP3K11 | 2.05586039 |
15 | MAP4K1 | 1.99059658 |
16 | MAP3K6 | 1.98828269 |
17 | ZAP70 | 1.88164821 |
18 | TAOK2 | 1.86180654 |
19 | TRPM7 | 1.80619949 |
20 | CDK19 | 1.79440535 |
21 | TYK2 | 1.77471376 |
22 | BLK | 1.77460453 |
23 | PIK3CG | 1.68924035 |
24 | SCYL2 | 1.54538778 |
25 | IRAK4 | 1.50025651 |
26 | KDR | 1.43596875 |
27 | MAP3K3 | 1.43113474 |
28 | LYN | 1.42809243 |
29 | HCK | 1.30156709 |
30 | CDK6 | 1.28903419 |
31 | BMPR2 | 1.26736102 |
32 | TBK1 | 1.22061356 |
33 | CDK12 | 1.20369133 |
34 | CSF1R | 1.12664804 |
35 | ITK | 1.08174678 |
36 | TAOK3 | 1.06146166 |
37 | MAP3K14 | 1.05505452 |
38 | FLT3 | 1.01563511 |
39 | TRIB3 | 0.97414774 |
40 | JAK2 | 0.96383116 |
41 | MAPK4 | 0.92305910 |
42 | HIPK2 | 0.90116331 |
43 | MAP3K5 | 0.88231803 |
44 | MAP3K1 | 0.87442438 |
45 | MAP2K6 | 0.83041083 |
46 | MAP2K4 | 0.79526049 |
47 | LCK | 0.79274635 |
48 | RPS6KA4 | 0.77640765 |
49 | MOS | 0.76903898 |
50 | FGR | 0.74963938 |
51 | MARK3 | 0.74444839 |
52 | CDK4 | 0.74399057 |
53 | PDK1 | 0.72188234 |
54 | RPS6KL1 | 0.71970264 |
55 | RPS6KC1 | 0.71970264 |
56 | PDPK1 | 0.69572439 |
57 | EIF2AK1 | 0.67733632 |
58 | ABL2 | 0.66856477 |
59 | IKBKE | 0.66401850 |
60 | LRRK2 | 0.66278061 |
61 | CLK1 | 0.65495142 |
62 | CSK | 0.65233829 |
63 | PTK2B | 0.63581754 |
64 | MAP3K13 | 0.62999880 |
65 | RPS6KA6 | 0.62368137 |
66 | TXK | 0.62164705 |
67 | MAPK12 | 0.60574706 |
68 | MAP2K2 | 0.59999839 |
69 | GRK7 | 0.59500324 |
70 | IKBKB | 0.59035461 |
71 | TGFBR2 | 0.58748517 |
72 | PIM1 | 0.58163280 |
73 | JAK3 | 0.56811386 |
74 | DAPK2 | 0.55011778 |
75 | PLK4 | 0.54462462 |
76 | YES1 | 0.52044035 |
77 | PIK3CA | 0.51900498 |
78 | MATK | 0.50975842 |
79 | STK10 | 0.48222599 |
80 | PRKCQ | 0.48118013 |
81 | BCKDK | 0.47407885 |
82 | BRD4 | 0.46252957 |
83 | RPS6KB2 | 0.40984650 |
84 | VRK2 | 0.40983291 |
85 | RPS6KA5 | 0.39667936 |
86 | MARK2 | 0.39232007 |
87 | MAPKAPK2 | 0.38433614 |
88 | ABL1 | 0.37812985 |
89 | VRK1 | 0.34558624 |
90 | PRKCD | 0.33946878 |
91 | MAP3K8 | 0.33587689 |
92 | RET | 0.33366366 |
93 | GSK3A | 0.33075494 |
94 | MAPK3 | 0.32997379 |
95 | STK11 | 0.32757948 |
96 | MAPK11 | 0.32235911 |
97 | MKNK1 | 0.30768512 |
98 | GRK5 | 0.30347094 |
99 | NEK2 | 0.29858512 |
100 | RPS6KA2 | 0.28255137 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.46277353 |
2 | Malaria_Homo sapiens_hsa05144 | 3.38135385 |
3 | * Asthma_Homo sapiens_hsa05310 | 3.25008164 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.15929809 |
5 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.72896601 |
6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.66023114 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55614650 |
8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.29943342 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17381831 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14767138 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10490934 |
12 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.01501147 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97617254 |
14 | DNA replication_Homo sapiens_hsa03030 | 1.88027224 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75661941 |
16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74983580 |
17 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.73844160 |
18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71614670 |
19 | Tuberculosis_Homo sapiens_hsa05152 | 1.67309214 |
20 | Platelet activation_Homo sapiens_hsa04611 | 1.49030370 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48587086 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48442540 |
23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39647726 |
24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34200835 |
25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33501008 |
26 | Base excision repair_Homo sapiens_hsa03410 | 1.33154198 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.29562924 |
28 | Ribosome_Homo sapiens_hsa03010 | 1.29404226 |
29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27338853 |
30 | Amoebiasis_Homo sapiens_hsa05146 | 1.26013340 |
31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24785746 |
32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19201108 |
33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14678565 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14581804 |
35 | Legionellosis_Homo sapiens_hsa05134 | 1.14476440 |
36 | Phagosome_Homo sapiens_hsa04145 | 1.13922350 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10798544 |
38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09187257 |
39 | Allograft rejection_Homo sapiens_hsa05330 | 1.08775092 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.08324738 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05811879 |
42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04647517 |
43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04521836 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03841806 |
45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03618936 |
46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00723217 |
47 | Pertussis_Homo sapiens_hsa05133 | 0.98242398 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97213281 |
49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96477448 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96353902 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93468232 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92763201 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.88080659 |
54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83499641 |
55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82414533 |
56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81602475 |
57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80515537 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80304964 |
59 | Measles_Homo sapiens_hsa05162 | 0.79802799 |
60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76944574 |
61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75986553 |
62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75417686 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72072068 |
64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70698950 |
65 | Shigellosis_Homo sapiens_hsa05131 | 0.65422974 |
66 | Salivary secretion_Homo sapiens_hsa04970 | 0.63608933 |
67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63441474 |
68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62676677 |
69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60299585 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60144523 |
71 | Salmonella infection_Homo sapiens_hsa05132 | 0.59784060 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56509987 |
73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55768427 |
74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55676574 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50385750 |
76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50125084 |
77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48624640 |
78 | Hepatitis C_Homo sapiens_hsa05160 | 0.48135994 |
79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47137839 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47066595 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46885121 |
82 | Apoptosis_Homo sapiens_hsa04210 | 0.44734814 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44218589 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41798738 |
85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41537229 |
86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41130819 |
87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39177167 |
88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37413495 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37379445 |
90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35705937 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35527194 |
92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35444055 |
93 | Homologous recombination_Homo sapiens_hsa03440 | 0.34847981 |
94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34423967 |
95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33755308 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32614274 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.30247257 |
98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29993504 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29394400 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28904589 |